A significantly higher level of serum albumin level was observed in the NAFLD group (4.19±0.35 g/dl) than in participants without NAFLD (3.89 ±0.52 g/dL) (p-value: 0.022). The gene discussed is ALB; the disease is metabolic dysfunction-associated steatotic liver disease.